Ilenia Calcaterra: RESOLVE Study on Hypertrophic Synovium in Severe Hemophilia A Under Emicizumab
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared a post on LinkedIn:
“Honored to have presented our work on hypertrophic synovium in severe haemophilia A during the moderated poster session at the WFH 2026 World Congress in Kuala Lumpur.
It was a real privilege to be among the candidates for the Christine Lee Young Researcher Award for best poster and to share this moment with such talented young researchers from around the world.
Our study, RESOLVE, focused on changes in hypertrophic synovium in adult patients with severe haemophilia A receiving emicizumab prophylaxis.
The data suggest that while emicizumab provides excellent bleed control, meaningful improvement in synovial status can also be observed, reinforcing the importance of joint monitoring and individualized joint health management.
Grateful for this opportunity, for the scientific exchange, and for the chance to contribute to ongoing research in haemophilia care.”
Find more posts featuring Ilenia Calcaterra on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers